Evaluation of the Repeatability and Reproducibility of AngioVue

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-29

Study Completion Date

2017-02-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the repeatability and reproducibility of measurements of the vascular structures and the anatomical structures of the posterior pole of the eye based on AngioVue volume scans in normal subjects, glaucoma patients, and retina patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT

NCT02781948

Cornea

COMPLETED

Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT

NCT02600546

Repeatability & Reproducibility

COMPLETED

Evaluation of OCT Measurements

NCT01806402

Assess Eye Measurements in Patients Having Retina Pathology or Glaucoma

COMPLETED

Prospective, Randomized, Controlled Agreement and Reproducibility Clinical Study

NCT05026658

Digital Acuity Product

COMPLETED NA

Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

NCT03833830

Neovascular Age-related Macular Degeneration

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Normal, Glaucoma & Retinal Pathology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal

Not having glaucoma or retinal pathology

Optical Coherence Tomography Angiography

Intervention Type DEVICE

Glaucoma

Having glaucoma.

Optical Coherence Tomography Angiography

Intervention Type DEVICE

Retina

Having retinal pathology

Optical Coherence Tomography Angiography

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Optical Coherence Tomography Angiography

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Normal

* Age \> 18.
* No retinal pathology or glaucoma.
2. Glaucoma patient

* Age \> 18.
* Have glaucoma.
3. Retina patient

* Age \> 18.
* Have retina pathology.

Exclusion Criteria

1. Normal

* Unable to complete required exams.
* Poor quality image data.
2. Glaucoma patient

* Unable to complete required exams.
* Poor quality image data.
* Retinal pathology.
3. Retina patient

* Unable to complete required exams.
* Poor quality image data.
* Glaucoma.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes